Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 抑制剂/激动剂 /
G蛋白偶联受体/G蛋白
神经信号通路
/ 5-羟色胺受体 / Ondansetron

昂丹司琼 /Ondansetron {[allProObj[0].p_purity_real_show]}

货号：A150812 同义名： 恩丹西酮 / SN 307;GR 38032 Ambeed 开学季，买赠积分，赢豪礼

Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Ondansetron 化学结构 CAS号：99614-02-5
Ondansetron 化学结构
CAS号：99614-02-5
Ondansetron 3D分子结构
CAS号：99614-02-5
Ondansetron 化学结构 CAS号：99614-02-5
Ondansetron 3D分子结构 CAS号：99614-02-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Ondansetron 纯度/质量文件 产品仅供科研

货号：A150812 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• JACS Au, 2024. Ambeed. [ A148168 ]
• JMC, 2024. Ambeed. [ A187643 ]
• JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
• Biomacromolecules, 2024. Ambeed. [ A110759 ]
• Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 5-HT ↓ 5-HT1 ↓ 5-HT2 ↓ 5-HT3 ↓ 5-HT5 ↓ 5-HT6 ↓ 5-HT7 ↓ 其他靶点 纯度
Desvenlafaxine ++

5-HT, Ki: 40.2 nM

 		{[allProObj[0].p_purity_real_show]}
Lamotrigine +

5-HT (rat brain synaptosomes), IC50: 474 μM

5-HT (human platelets), IC50: 240 μM

 		{[allProObj[0].p_purity_real_show]}
Venlafaxine ✔ {[allProObj[0].p_purity_real_show]}
Fluvoxamine maleate ✔ {[allProObj[0].p_purity_real_show]}
Iloperidone ✔ {[allProObj[0].p_purity_real_show]}
Ziprasidone HCl ✔ {[allProObj[0].p_purity_real_show]}
Atomoxetine HCI +

5-HT, Ki: 77 nM

 		{[allProObj[0].p_purity_real_show]}
Dapoxetine HCl ✔ {[allProObj[0].p_purity_real_show]}
Trazodone ✔ {[allProObj[0].p_purity_real_show]}
Clomipramine HCl ✔ {[allProObj[0].p_purity_real_show]}
Mirtazapine ✔ {[allProObj[0].p_purity_real_show]}
Escitalopram oxalate +++

5-HT, Ki: 0.89 nM

 		{[allProObj[0].p_purity_real_show]}
Duloxetine ✔ {[allProObj[0].p_purity_real_show]}
Sertraline HCl ++

5-HT, Ki: 13 nM

 		{[allProObj[0].p_purity_real_show]}
Citalopram HBr +++

serotonin reuptake, IC50: 1.8 nM

 		{[allProObj[0].p_purity_real_show]}
Latrepirdine 2HCl ✔ GluR {[allProObj[0].p_purity_real_show]}
Fluoxetine HCl ✔ {[allProObj[0].p_purity_real_show]}
Paroxetine hydrochloride ✔ AChR {[allProObj[0].p_purity_real_show]}
BMY 7378 ++

5-HT1D, pIC50: 5.9

5-HT1A, pIC50: 6.4

 		+

5-HT2, pIC50: 5.5

 		{[allProObj[0].p_purity_real_show]}
Flibanserin +++

5-HT1A, Ki: 1 nM

 		+

5-HT2A, Ki: 49 nM

 		{[allProObj[0].p_purity_real_show]}
LY310762 +

5-HT1D, Ki: 249 nM

 		{[allProObj[0].p_purity_real_show]}
Cyclobenzaprine HCI ✔ {[allProObj[0].p_purity_real_show]}
Blonanserin +++

5-HT2, Ki: 3.98 nM

 		{[allProObj[0].p_purity_real_show]}
Cyproheptadine HCl ++++

5-HT2, IC50: 0.6 nM

 		{[allProObj[0].p_purity_real_show]}
Olanzapine ✔ {[allProObj[0].p_purity_real_show]}
Pimavanserin hemitartrate +++

5-HT2A, pIC50: 8.7

 		{[allProObj[0].p_purity_real_show]}
Ketanserin +++

5-HT2C (Rat), Ki: 50 nM

5-HT2C (Human), Ki: 2.5 nM

 		{[allProObj[0].p_purity_real_show]}
Loxapine succinate ++

5-HT2 (human), Ki: 6.8 nM

5-HT2 (bovine), Ki: 6.6 nM

 		{[allProObj[0].p_purity_real_show]}
Agomelatine ✔ {[allProObj[0].p_purity_real_show]}
Clozapine ✔ {[allProObj[0].p_purity_real_show]}
Amitriptyline +

5-HT2, Ki: 235 nM

 		SERT {[allProObj[0].p_purity_real_show]}
PRX-08066 maleate +++

5-HT2B, IC50: 3.4 nM

 		{[allProObj[0].p_purity_real_show]}
RS-127445 ++++

5-HT2B, pIC50: 10.4

5-HT2B, pKi: 9.5

 		{[allProObj[0].p_purity_real_show]}
Sarpogrelate HCl ++++

5-HT2C, Kd: 1.1 nM

5-HT2A, Kd: 2.1 nM

 		{[allProObj[0].p_purity_real_show]}
Tropisetron ✔ {[allProObj[0].p_purity_real_show]}
Palonosetron ✔ {[allProObj[0].p_purity_real_show]}
Ramosetron HCl ++++

5-HT3 receptor, Ki: 0.091 nM

 		{[allProObj[0].p_purity_real_show]}
Ondansetron ✔ {[allProObj[0].p_purity_real_show]}
Granisetron ✔ {[allProObj[0].p_purity_real_show]}
Alosetron HCl ✔ {[allProObj[0].p_purity_real_show]}
Ondansetron hydrochloride dihydrate ✔ {[allProObj[0].p_purity_real_show]}
VUF10166 ++++

5-HT3AB, Ki: 22 nM

5-HT3A, Ki: 0.04 nM

 		{[allProObj[0].p_purity_real_show]}
Azasetron hydrochloride ++++

5-HT3, IC50: 0.33 nM

 		{[allProObj[0].p_purity_real_show]}
Asenapine maleate +++

5-HT1A, pKi: 8.6

5-HT1B, pKi: 8.4

 		++++

5-HT2C, pKi: 10.46

5-HT2A, pKi: 9.75

 		+++

5-HT5A, pKi: 8.84

 		++++

5-HT6, pKi: 9.6

 		++++

5-HT7, pKi: 9.94

 		{[allProObj[0].p_purity_real_show]}
Risperidone ++

5-HT1D, Ki: 84.6 nM

5-HT1B, Ki: 14.9 nM

 		++++

5-HT2C, Ki: 12 nM

5-HT2A, Ki: 61.9 nM

 		+

5-HT5A, Ki: 206 nM

 		++

5-HT7, Ki: 6.6 nM

 		{[allProObj[0].p_purity_real_show]}
SB 271046 HCl +++

5-HT6, pKi: 8.92

 		{[allProObj[0].p_purity_real_show]}
Intepirdine ++++

5-HT6, pKi: 9.63

 		{[allProObj[0].p_purity_real_show]}
SB-269970 HCl ++

5-HT7, pKi: 8.3

 		{[allProObj[0].p_purity_real_show]}
BRL 15572 ++

5-HT1D, pKi: 6

5-HT1B, pKi: 6.1

 		++

5-HT2A, pKi: 6.6

5-HT2B, pKi: 6.2

 		+

5-HT6, pKi: 5.9

 		+

5-HT7, pKi: 6.3

 		{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Ondansetron 生物活性

靶点

  • 5-HT3
描述 Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy[3]. The 5-HT3A receptor antagonist ondansetron (0.3 nM) reversibly inhibited the 5-HT (30 mM) signal by 70% and at 3 nM it abolished the response[4]. Acute ondansetron administration at the lowest dose (0.1 mg/kg, IP) tested had no effect, while other doses (0.33 and 1 mg/kg, IP) produced improvements in auditory gating[5]. Different doses of ondansetron were injected intraperitoneally (i.p.) at fixed times during the day to determine both the sublethal (TD50) and lethal (LD50) doses, which were, respectively, 3.7 +/- 0.6 mg/kg and 4.6 +/- 0.5 mg/kg[6]. Ondansetron (0.25-1.0 mg/kg, subcutaneously) given before the challenge dose of ethanol (2.4 g/kg, intraperitoneally) injection, significantly and dose dependently attenuated the expression of sensitization. In addition, ondansetron (1.0 mg/kg, subcutaneously) given before ethanol injection on days 1, 4, 7, and 10 significantly blocked the development (days 1, 4, 7, and 10), and expression (day 15) of sensitization to the locomotor stimulant effect of ethanol injection[7]. Ondansetron has shown good efficacy in the prevention of acute nausea and vomiting in children receiving moderately or highly emetogenic chemotherapy and/or irradiation, particularly when combined with dexamethasone[8].

Ondansetron 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02436798 - Recruiting January 2019 Canada, British Columbia ... 展开 >> Children's and Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Bruce Carleton, PharmD.    604-875-2179    bcarleton@popi.ubc.ca    Principal Investigator: Bruce Carleton, PharmD. 收起 <<
NCT01640340 Malignant Neoplasm Not Applicable Completed - United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 <<
NCT00967499 Postoperative Nausea and Vomit... 展开 >>ing 收起 << Phase 2 Completed - United States, Arizona ... 展开 >> Precision Trials Phoenix, Arizona, United States, 85032 United States, California Accurate Clinical Trials, Inc Laguna Hills, California, United States, 92653 University of California San Francisco San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas Scott and White Hospital Temple, Texas, United States, 76508 收起 <<

Ondansetron 参考文献

[1]Wildeboer KM, Zheng L, et al. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Res. 2009 Dec 1;1300:41-50. doi: 10.1016/j.brainres.2009.08.075.

[2]Umathe SN, Bhutada PS, et al. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behav Pharmacol. 2009 Feb;20(1):78-83.

[3]Brown AM, Hope AG, Lambert JJ, Peters JA. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol. 1998 Mar 15;507 (Pt 3)(Pt 3):653-65

[4]Barann M, Meder W, Dorner Z, Brüss M, Bönisch H, Göthert M, Urban BW. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):255-65

[5]Wildeboer KM, Zheng L, Choo KS, Stevens KE. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Res. 2009 Dec 1;1300:41-50

[6]Khedhaier A, Ben Attia M, Gadacha W, Sani M, Bouzouita K, Chouchane L, Mechkouri M, Reinberg A, Boughattas NA. Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. Chronobiol Int. 2003 Nov;20(6):1103-16

[7]Umathe SN, Bhutada PS, Raut VS, Jain NS, Mundhada YR. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behav Pharmacol. 2009 Feb;20(1):78-83.

[8]Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an antiemetic in children. Paediatr Drugs. 2001;3(6):441-79

Ondansetron 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.41mL

0.68mL

0.34mL

17.04mL

3.41mL

1.70mL

34.09mL

6.82mL

3.41mL

Ondansetron 技术信息

CAS号99614-02-5
分子式C18H19N3O
分子量 293.363
别名 恩丹西酮 ;SN 307;GR 38032;NSC 665799;GR 38032F;Ondansetron (hydrochloride) (CRM)
运输蓝冰
存储条件

粉末 Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月
溶解度

DMSO: 9 mg/mL(30.68 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方

Tags: Ondansetron | 99614-02-5 | GR 38032 | SN 307 | GR38032 | GR-38032 | SN307 | SN 307 | SN-307 | 5-HT Receptor Antagonist | GPCR/G Protein | Neuronal Signaling | 5-HT Receptor | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Ondansetron 纯度/质量文件 | Ondansetron 亚型比较 | Ondansetron 生物活性 | Ondansetron 临床数据 | Ondansetron 参考文献 | Ondansetron 实验方案 | Ondansetron 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z